Heron Therapeutics expects Q2 revenue of $42.2M
Heron Therapeutics is set to announce its Q2 2026 earnings on August 10th.
The company’s consensus EPS estimate is -$0.02, flat year-over-year, while the consensus revenue estimate is $42.2M, a 13.4% increase from the same period last year.
The earnings report will provide insight into the company’s performance over the last quarter.